ES529170A0 - El agente antitumoral rebecamicina - Google Patents

El agente antitumoral rebecamicina

Info

Publication number
ES529170A0
ES529170A0 ES529170A ES529170A ES529170A0 ES 529170 A0 ES529170 A0 ES 529170A0 ES 529170 A ES529170 A ES 529170A ES 529170 A ES529170 A ES 529170A ES 529170 A0 ES529170 A0 ES 529170A0
Authority
ES
Spain
Prior art keywords
rebecamicina
antitumoral agent
rebeccamycin
atcc
fermentation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES529170A
Other languages
English (en)
Other versions
ES8607396A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Co
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of ES529170A0 publication Critical patent/ES529170A0/es
Publication of ES8607396A1 publication Critical patent/ES8607396A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/044—Pyrrole radicals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/02—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using fungi
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • C12P19/28—N-glycosides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/365—Nocardia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Mycology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Hematology (AREA)
  • Communicable Diseases (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
ES529170A 1983-01-28 1984-01-26 El agente antitumoral rebecamicina Expired ES8607396A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/461,817 US4487925A (en) 1983-01-28 1983-01-28 Rebeccamycin and process for its preparation

Publications (2)

Publication Number Publication Date
ES529170A0 true ES529170A0 (es) 1986-05-16
ES8607396A1 ES8607396A1 (es) 1986-05-16

Family

ID=23834041

Family Applications (1)

Application Number Title Priority Date Filing Date
ES529170A Expired ES8607396A1 (es) 1983-01-28 1984-01-26 El agente antitumoral rebecamicina

Country Status (15)

Country Link
US (1) US4487925A (es)
EP (1) EP0115350B1 (es)
JP (1) JPS59141597A (es)
KR (1) KR910002856B1 (es)
AT (1) ATE36540T1 (es)
AU (1) AU564256B2 (es)
CA (1) CA1220149A (es)
DE (1) DE3473459D1 (es)
DK (1) DK160429C (es)
ES (1) ES8607396A1 (es)
FI (1) FI77264C (es)
GR (1) GR81748B (es)
IE (1) IE56651B1 (es)
PT (1) PT78019B (es)
ZA (1) ZA84582B (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4524145A (en) * 1984-09-04 1985-06-18 Bristol-Myers Company 4'-Deschlororebeccamycin pharmaceutical composition and method of use
US4567143A (en) * 1984-09-04 1986-01-28 Bristol-Myers Company Process for preparing 4'-deschlororebeccamycin
US4743594A (en) * 1984-09-17 1988-05-10 Schering Corporation Antibiotic, antitumor compounds and their use
US4764510A (en) * 1986-04-11 1988-08-16 Eli Lilly And Company Antibiotic A42125 and process for its production
US4808613A (en) * 1986-11-21 1989-02-28 Bristol-Myers Company Rebeccamycin derivative containing pharmaceutical composition
US4785085A (en) * 1986-11-21 1988-11-15 Bristol-Myers Company Rebeccamycin analogs
US5158938A (en) * 1990-03-06 1992-10-27 Bristol-Myers Squibb Company Rebeccamycin
IL97233A (en) * 1990-03-06 1995-03-30 Bristol Myers Squibb Co Analogs of rabamycin, their manufacture and pharmaceutical preparations containing them
US5344823A (en) * 1990-03-06 1994-09-06 Bristol-Myers Squibb Company Antitumor antibiotic BMY-41219
EP0445736A1 (en) * 1990-03-06 1991-09-11 Bristol-Myers Squibb Company Rebeccamycin analog and pharmaceutical composition containing it
US5478813A (en) * 1990-05-11 1995-12-26 Banyu Pharmaceutical Co., Ltd. Antitumor substance BE-13793C derivatives
ES2125976T3 (es) * 1992-03-20 1999-03-16 Wellcome Found Otros derivados de indol con accion antiviral.
US6677450B2 (en) 2000-10-06 2004-01-13 Bristol-Myers Squibb Company Topoisomerase inhibitors
US6610727B2 (en) 2000-10-06 2003-08-26 Bristol-Myers Squibb Company Anhydro sugar derivatives of indolocarbazoles
US6653290B2 (en) * 2000-10-06 2003-11-25 Bristol-Myers Squibb Company Tumor proliferation inhibitors
WO2002077255A1 (en) 2001-03-22 2002-10-03 Bristol-Myers Squibb Company Topoisomerase i selective cytotoxic sugar derivatives of indolopyrrolocarbazoles
ES2326459B1 (es) 2008-04-08 2010-05-28 Universidad De Oviedo Indolocarbazoles glicosilados, su procedimiento de obtencion y sus usos.
FR2956934B1 (fr) 2010-02-26 2012-09-28 Blink E Procede et dispositif d'emission/reception de signaux electromagnetiques recus/emis sur une ou plusieurs premieres bandes de frequences.
FR2990315B1 (fr) 2012-05-04 2014-06-13 Blink E Procede de transmission d'informations entre une unite emettrice et une unite receptrice

Also Published As

Publication number Publication date
PT78019A (en) 1984-02-01
AU564256B2 (en) 1987-08-06
US4487925A (en) 1984-12-11
DK35684A (da) 1984-07-29
IE56651B1 (en) 1991-10-23
IE840201L (en) 1984-07-28
EP0115350B1 (en) 1988-08-17
ES8607396A1 (es) 1986-05-16
GR81748B (es) 1984-12-12
FI840301A0 (fi) 1984-01-25
FI77264C (fi) 1989-02-10
JPH0452280B2 (es) 1992-08-21
FI77264B (fi) 1988-10-31
AU2372084A (en) 1984-08-02
EP0115350A3 (en) 1985-09-18
DK160429C (da) 1991-08-19
EP0115350A2 (en) 1984-08-08
KR840007257A (ko) 1984-12-06
DK35684D0 (da) 1984-01-26
JPS59141597A (ja) 1984-08-14
KR910002856B1 (ko) 1991-05-06
FI840301A (fi) 1984-07-29
DK160429B (da) 1991-03-11
ZA84582B (en) 1984-09-26
DE3473459D1 (en) 1988-09-22
PT78019B (en) 1986-06-18
CA1220149A (en) 1987-04-07
ATE36540T1 (de) 1988-09-15

Similar Documents

Publication Publication Date Title
ES529170A0 (es) El agente antitumoral rebecamicina
ES2143620T3 (es) Polipeptidos modificados con actividad biologica incrementada.
MY103388A (en) Azithromycin and derivatives as antiprotozoal agents
GB1534822A (en) Dental chairs or like patient supporting devices
GB8922026D0 (en) Novel anti-viral and cytotoxic agent
ES8606289A1 (es) Un procedimiento para la preparacion de piridazinaminas.
MY110664A (en) Protein c derivatives
DE3586697D1 (en) Aktive thymopentin-analoga.
ES8706443A1 (es) Un procedimiento para preparar una solucion parenteral de activador de plasminogeno de tejido (t-pa)
SE8202439L (sv) 4'-jodderivat av antracyklinglykosider
ES2110009T3 (es) Derivados de la estreptolisina o.
HK32492A (en) Drug preparations of reduced toxicity
ES2120962T3 (es) Composicion antivirica.
AU591892B2 (en) Peptides
ES8704962A1 (es) Un procedimiento para preparar 1b-d-ribofuranosil, 1-2-4-triazol-3-carboxamida.
AU8640091A (en) Human interferon-gamma4-134, functional equivalents thereof and methods of using and compositions employing these materials
GB1420777A (en) Coumarin and coumarinimide compounds
JPS5524150A (en) Anti-malignant-tumor agent
GB8407990D0 (en) Macrole antibiotics
JPS52108085A (en) Immobilized deacylating enzyme and preparation of deacylated derivativ es of macrolide antibiotics using the same
BG52177B2 (en) Cardioplegic solution
UA25538C2 (uk) Протипаразитарний та антимікробний лікарський засіб для місцевого застосування
JPS523079A (en) Prepartion of amionuclesides
JPS5366494A (en) Preparation of antibiotics pa-399
ES1004815U (es) Silla de asiento suspendido.